


The Fund aims to achieve long-term capital growth through investment in North American securities using a value based investment philosophy.
| Name | % Net Assets |
|---|---|
| Lincoln National | 2.7% |
| Merck & Co | 2.6% |
| Nucor | 2.6% |
| JP Morgan | 2.6% |
| Hartford Financial | 2.5% |
| Morgan Stanley | 2.5% |
| Wells Fargo | 2.5% |
| Pfizer | 2.5% |
| Apache | 2.5% |
| Cigna | 2.5% |
| Key | % Net Assets |
|---|---|
| 2.7% | |
| 2.6% | |
| 2.6% | |
| 2.6% | |
| 89.5% |
| Date | 23-Jun-2022 |
|---|---|
| NAV | 178.61p |
| Currency | GBP |
| Change | 1.98p |
| % | 1.12% |
| YTD change | 178.61p |
| YTD % | n/a |
| Fund Inception | 01/07/2005 |
|---|---|
| Fund Manager | Richard Brody |
| TER | 1.68 (28-Feb-2014) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | £10 |
| Savings | £10 |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | 4.50% |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.02 |
You are here: research